452 related articles for article (PubMed ID: 27710981)
1. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.
Al-Mandeel HM; Sagr E; Sait K; Latifah HM; Al-Obaid A; Al-Badawi IA; Alkushi AO; Salem H; Massoudi NS; Schunemann H; Mustafa RA; Brignardello-Petersen R
Ann Saudi Med; 2016; 36(5):313-320. PubMed ID: 27710981
[TBL] [Abstract][Full Text] [Related]
2. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
3. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
5. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
7. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
8. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.
Santesso N; Mustafa RA; Schünemann HJ; Arbyn M; Blumenthal PD; Cain J; Chirenje M; Denny L; De Vuyst H; Eckert LO; Forhan SE; Franco EL; Gage JC; Garcia F; Herrero R; Jeronimo J; Lu ER; Luciani S; Quek SC; Sankaranarayanan R; Tsu V; Broutet N;
Int J Gynaecol Obstet; 2016 Mar; 132(3):252-8. PubMed ID: 26868062
[TBL] [Abstract][Full Text] [Related]
9. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
[TBL] [Abstract][Full Text] [Related]
10. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds.
Polman NJ; Veldhuijzen NJ; Heideman DAM; Snijders PJF; Meijer CJLM; Berkhof J
Int J Cancer; 2019 May; 144(9):2339-2346. PubMed ID: 30565673
[TBL] [Abstract][Full Text] [Related]
11. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
[TBL] [Abstract][Full Text] [Related]
12. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
[TBL] [Abstract][Full Text] [Related]
14. Natural history and clearance of HPV after treatment of precancerous cervical lesions.
Aerssens A; Claeys P; Garcia A; Sturtewagen Y; Velasquez R; Vanden Broeck D; Vansteelandt S; Temmerman M; Cuvelier CA
Histopathology; 2008 Feb; 52(3):381-6. PubMed ID: 18269589
[TBL] [Abstract][Full Text] [Related]
15. The impact of primary human papillomavirus screening on negative loop excision histology following biopsy-proven high-grade cervical intra-epithelial lesions: A review from a large tertiary colposcopy unit.
Xie H; Morton R; Balendran J; Philp S; Saidi S; Farrell R; Anderson L; Pather S
Aust N Z J Obstet Gynaecol; 2021 Dec; 61(6):941-948. PubMed ID: 34506036
[TBL] [Abstract][Full Text] [Related]
16. Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile.
Ferreccio C; Barriga MI; Lagos M; Ibáñez C; Poggi H; González F; Terrazas S; Katki HA; Núñez F; Cartagena J; Van De Wyngard V; Viñales D; Brañes J
Int J Cancer; 2013 Feb; 132(4):916-23. PubMed ID: 22684726
[TBL] [Abstract][Full Text] [Related]
17. Human telomerase gene and high-risk human papillomavirus infection are related to cervical intraepithelial neoplasia.
Zhao XY; Cui Y; Jiang SF; Liu KJ; Han HQ; Liu XS; Li Y
Asian Pac J Cancer Prev; 2015; 16(2):693-7. PubMed ID: 25684510
[TBL] [Abstract][Full Text] [Related]
18. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
20. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
